SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TCM informs about board meeting

26 May 2018 Evaluate

TCM has informed about the board at their meeting held today has approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2018, and recommend the final dividend of Re 0.30 (i.e. 30%) per equity share of the face value of Re 1 each for the financial year ended 31st March, 2018, subject to the approval of the shareholders at the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

TCM Share Price

44.50 -1.00 (-2.20%)
11-Jun-2026 15:31 View Price Chart
Peers
Company Name CMP
SRF 2653.00
BASF India 3250.00
Tata Chemicals 741.70
Pidilite Inds. 1500.25
Deepak Nitrite 1618.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: